Pardes Biosciences Performance
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Pardes Biosciences are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Pardes Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Pardes Biosciences is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 268.7 M | |
| Total Cashflows From Investing Activities | -137 M |
Pardes |
Pardes Biosciences Relative Risk vs. Return Landscape
If you would invest (100.00) in Pardes Biosciences on December 22, 2024 and sell it today you would earn a total of 100.00 from holding Pardes Biosciences or generate -100.0% return on investment over 90 days. Pardes Biosciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Pardes, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Pardes Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pardes Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pardes Biosciences, and traders can use it to determine the average amount a Pardes Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PRDS |
Based on monthly moving average Pardes Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pardes Biosciences by adding Pardes Biosciences to a well-diversified portfolio.
Pardes Biosciences Fundamentals Growth
Pardes Stock prices reflect investors' perceptions of the future prospects and financial health of Pardes Biosciences, and Pardes Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pardes Stock performance.
| Return On Equity | -0.4 | |||
| Return On Asset | -0.26 | |||
| Current Valuation | (22.1 M) | |||
| Shares Outstanding | 62.01 M | |||
| Price To Book | 0.37 X | |||
| EBITDA | (99.82 M) | |||
| Cash And Equivalents | 228.6 M | |||
| Cash Per Share | 3.67 X | |||
| Book Value Per Share | 2.57 X | |||
| Cash Flow From Operations | (71.98 M) | |||
| Earnings Per Share | (1.28) X | |||
| Total Asset | 200.62 M | |||
| Retained Earnings | (148.16 M) | |||
Things to note about Pardes Biosciences performance evaluation
Checking the ongoing alerts about Pardes Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pardes Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pardes Biosciences is not yet fully synchronised with the market data | |
| Pardes Biosciences has some characteristics of a very speculative penny stock | |
| Pardes Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (96.63 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Pardes Biosciences currently holds about 228.6 M in cash with (71.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.67. | |
| Roughly 72.0% of the company shares are owned by institutional investors |
- Analyzing Pardes Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pardes Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Pardes Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pardes Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pardes Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pardes Biosciences' stock. These opinions can provide insight into Pardes Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Pardes Stock
If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |